Literature DB >> 27416979

Association Between Financial Conflicts of Interests and Supportive Opinions for Erectile Dysfunction Treatment.

Rafael Boscolo-Berto1, Massimo Montisci2, Silvia Secco3, Carolina D'Elia4, Rosella Snenghi2, Guido Viel2, Santo Davide Ferrara2.   

Abstract

A conflict of interest (COI) is a situation in which a person has competing loyalties or interests that make it difficult to fulfil his or her duties impartially. Conflict of interest is not categorically improper in itself but requires proper management. A SCOPUS literature search was performed for publications on the efficacy/safety of Phospho-Di-Esterase Inhibitors (PDEIs) for treating erectile dysfunction. A categorization tool (CoOpCaT) was used to review and classify the publications as supportive/not-supportive for the discussed active ingredient and reporting or not reporting a COI for that specific drug or for the remaining PDEIs (i.e. competitors). Multivariable binary logistic regression was performed. In the 419 selected records the prevalence of supportive opinions was higher when a COI for the index label was declared. The CoOpCaT showed good internal consistency, discriminative validity and intra/inter-rater agreement. The strongest predictor for a supportive opinion was the total number of financial COIs for the index label. A mild protective effect of the total number of financial COIs for any competitor label was noted. Financial COIs have frequently been associated with bias, and the measures currently adopted to restrain it lack effectiveness. Some evidence for monitoring and/or compensating this bias is reported here, but the ultimate solution remains distant.

Entities:  

Keywords:  Bias; Conflict of interest; Ethics; Financial disclosure; Sponsor

Mesh:

Substances:

Year:  2016        PMID: 27416979     DOI: 10.1007/s11673-016-9732-2

Source DB:  PubMed          Journal:  J Bioeth Inq        ISSN: 1176-7529            Impact factor:   1.352


  26 in total

1.  Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

Authors:  Bodil Als-Nielsen; Wendong Chen; Christian Gluud; Lise L Kjaergard
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

2.  Has the hunt for conflicts of interest gone too far? No.

Authors:  Kirby Lee
Journal:  BMJ       Date:  2008-03-01

3.  Non-financial conflicts of interests in psychiatric research and practice.

Authors:  Mario Maj
Journal:  Br J Psychiatry       Date:  2008-08       Impact factor: 9.319

4.  Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.

Authors:  Rachel P Riechelmann; Lisa Wang; Aoife O'Carroll; Monika K Krzyzanowska
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

5.  Sponsorship bias in clinical research.

Authors:  Joel Lexchin
Journal:  Int J Risk Saf Med       Date:  2012

6.  Revisiting financial conflicts of interest in FDA advisory committees.

Authors:  Genevieve Pham-Kanter
Journal:  Milbank Q       Date:  2014-09       Impact factor: 4.911

7.  Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications.

Authors:  Joel Lexchin
Journal:  Sci Eng Ethics       Date:  2011-02-15       Impact factor: 3.525

Review 8.  Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review.

Authors:  Amy T Wang; Christopher P McCoy; Mohammad Hassan Murad; Victor M Montori
Journal:  BMJ       Date:  2010-03-18

9.  Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles.

Authors:  Adriane Fugh-Berman; Christina Pike McDonald; Alicia M Bell; Emily Catherine Bethards; Anthony R Scialli
Journal:  PLoS Med       Date:  2011-03-15       Impact factor: 11.069

10.  Financial Conflicts of Interest Checklist 2010 for clinical research studies.

Authors:  Paula A Rochon; John Hoey; An-Wen Chan; Lorraine E Ferris; Joel Lexchin; Sunila R Kalkar; Melanie Sekeres; Wei Wu; Marleen Van Laethem; Andrea Gruneir; James Maskalyk; David L Streiner; Jennifer Gold; Nathan Taback; David Moher
Journal:  Open Med       Date:  2010-03-24
View more
  1 in total

1.  Photoselective vaporization of the prostate: study outcomes as a function of risk of bias, conflicts of interest, and industrial sponsorship.

Authors:  Marian S Wettstein; Clinsy Pazhepurackel; Aline S Neumann; Dixon T S Woon; Jaime O Herrera-Caceres; Marko Kozomara; Cédric Poyet; Tullio Sulser; Girish S Kulkarni; Thomas Hermanns
Journal:  World J Urol       Date:  2019-05-13       Impact factor: 4.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.